RECURRENT ENDOMETRIAL CANCER
Clinical trials for RECURRENT ENDOMETRIAL CANCER explained in plain language.
Never miss a new study
Get alerted when new RECURRENT ENDOMETRIAL CANCER trials appear
Sign up with your email to follow new studies for RECURRENT ENDOMETRIAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Two-Drug combo aims to keep aggressive uterine cancer at bay
Disease control Recruiting nowThis study is testing whether two drugs, abemaciclib and letrozole, can help control advanced or recurrent endometrial cancer after initial chemotherapy. The drugs are taken daily as maintenance therapy for up to two years to try to delay cancer progression. The trial will enroll…
Matched conditions: RECURRENT ENDOMETRIAL CANCER
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New hope for Tough-to-Treat gynecologic cancers
Disease control Recruiting nowThis study is testing a new drug called ubamatamab, given alone or with another drug (cemiplimab), for people with recurrent ovarian, fallopian tube, peritoneal, or endometrial cancers. The main goals are to find a safe and effective dose and to see if the treatment can shrink tu…
Matched conditions: RECURRENT ENDOMETRIAL CANCER
Phase: PHASE1, PHASE2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Mar 06, 2026 15:37 UTC